Hvilken er prisen på Novogene Co., Ltd. (688315)

Prisen på Novogene Co., Ltd. (688315) er $2.25

Hva er markedsverdien på Novogene Co., Ltd. (688315)

Markedsverdien på Novogene Co., Ltd. (688315) er $936.66M

Novogene Co., Ltd. (688315) Prishistorikk

Novogene Co., Ltd. is a global provider of comprehensive genomic services and advanced solutions. Its offerings span a wide array of genomic applications, including human, animal, plant, and microbial genome sequencing, alongside gene regulation and single-cell sequencing technologies. The company also specializes in cancer genomic profiling, whole exome sequencing (including clinical-grade versions), and FFPE RNA sequencing. Furthermore, Novogene develops proprietary tools such as NovoFocus, a next-generation sequencing (NGS)-based companion diagnostic for PARP inhibitor treatments, and NovoNeoantigen, a bioinformatics pipeline that identifies cancer neoantigens by analyzing whole exome and whole transcriptome sequencing data from matched tumor and normal samples. In a strategic collaboration, Novogene partners with Hummingbird Bioscience Pte. Ltd. to aid in the advancement of HMBD-001. This investigational anti-HER3 antibody is being assessed for its potential to treat diverse cancer types, notably those driven by NRG1-fusion. Established in 2011, Novogene Co., Ltd. operates from its headquarters in Beijing, China.

År	Ytelse
2026 (TTM)	8.20%
2025	2.58%
2024	-42.74%
2023	-17.48%
2022	-40.99%
2021	0.00%

År

Ytelse

2026 (TTM)

8.20%

2025

2.58%

2024

-42.74%

2023

-17.48%

2022

-40.99%

2021

0.00%

Selskap	Aksjepris	Endring 1år%	Land
Vertex Pharmaceuticals Incorporated VRTX.US	$542.09	38.63%	US
Argenx SE ARGX.US	$1.03K	44.13%	NL
CSL Limited CSL.AX	$121.53	-12.70%	AU
Moderna, Inc. MRNA.US	$138.18	473.58%	US
Lonza Group AG LONN.SW	$759.27	7.20%	CH

Selskap

Aksjepris

Endring 1år%

Land